Natus Medical is a provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, and neonatology, as well as newborn care products such as phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, software systems for managing and tracking disorders and diseases for public health laboratories, computer-based audiological, otoneurologic and vestibular instrumentation and sound rooms for hearing and balance care personnel. The NTUS stock yearly return is shown above.
The yearly return on the NTUS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2016 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NTUS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|